{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:33:17Z","timestamp":1793406797855,"version":"4.5.0"},"reference-count":139,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Inflammatory myofibroblastic tumor (IMT) is a rare neoplasm that is characterized by a proliferation of myofibroblastic and fibroblastic spindle cells, accompanied by an inflammatory infiltrate that is abundant in plasma cells, lymphocytes, and eosinophils. IMT can arise in various anatomical locations but most commonly occurs in the abdominal cavity, retroperitoneum, and lung, particularly in children and young adults. IMT typically demonstrates local invasion or recurrence, whereas metastasis is rare. IMTs pose a diagnostic challenge because of their overlapping morphological characteristics with a heterogeneous group of nonneoplastic and neoplastic lesions. Precise diagnosis is crucial for optimal management and accurate prognostication. Despite recent advancements in IMT diagnosis and treatment, its biological complexity and clinical management remain challenging due to significant histological heterogeneity and molecular genetic diversity. This review provides comprehensive updates on the clinical, molecular, and pathological characteristics of IMT, highlighting the diagnostic approaches and key differential diagnoses.<\/jats:p>","DOI":"10.3390\/cancers17081327","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T06:50:27Z","timestamp":1744699827000},"page":"1327","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["Inflammatory Myofibroblastic Tumor: An Updated Review"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8638-0360","authenticated-orcid":false,"given":"Joon Hyuk","family":"Choi","sequence":"first","affiliation":[{"name":"Department of Pathology, Yeungnam University College of Medicine, Daegu 42415, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"ref_1","unstructured":"The WHO Editorial Board (2020). Inflammatory myofibroblastic tumour. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_2","unstructured":"Lindberg, M.R. (2024). Diagnostic Pathology: Soft Tissue Tumors, Elsevier. [5th ed.]."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1365-2559.1984.tb02409.x","article-title":"The pulmonary plasma cell\/histiocytoma complex","volume":"8","author":"Spencer","year":"1984","journal-title":"Histopathology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/1097-0142(19870201)59:3<435::AID-CNCR2820590315>3.0.CO;2-6","article-title":"Angioinvasive plasma cell granulomas of the lung","volume":"59","author":"Warter","year":"1987","journal-title":"Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0022-3476(78)80903-2","article-title":"Abdominal plasma cell pseudotumor","volume":"93","author":"Pisciotto","year":"1978","journal-title":"J. Pediatr."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/1097-0142(19900401)65:7<1626::AID-CNCR2820650729>3.0.CO;2-V","article-title":"Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children","volume":"65","author":"Tang","year":"1990","journal-title":"Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00000478-198309000-00007","article-title":"Omental-mesenteric myxoid hamartomas. Infantile lesions simulating malignant tumors","volume":"7","author":"deMello","year":"1983","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0046-8177(88)80264-8","article-title":"Inflammatory pseudotumors of the lung: Progression from organizing pneumonia to fibrous histiocytoma or to plasma cell granuloma in 32 cases","volume":"19","author":"Matsubara","year":"1988","journal-title":"Hum. Pathol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1365-2559.1995.tb01521.x","article-title":"Inflammatory pseudotumour of soft tissues: A clinicopathological and immunohistochemical analysis of 18 cases","volume":"27","author":"Ramachandra","year":"1995","journal-title":"Histopathology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jcp.26.12.943","article-title":"Inflammatory pseudo-tumours of the abdomen: Plasma cell granulomas","volume":"26","author":"Wu","year":"1973","journal-title":"J. Clin. Pathol."},{"key":"ref_11","first-page":"102","article-title":"Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: An historical review with differential diagnostic considerations","volume":"15","author":"Coffin","year":"1998","journal-title":"Semin. Diagn. Pathol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/00000478-199112000-00005","article-title":"Inflammatory fibrosarcoma of the mesentery and retroperitoneum. A tumor closely simulating inflammatory pseudotumor","volume":"15","author":"Meis","year":"1991","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1136\/jcp.2007.049387","article-title":"Inflammatory myofibroblastic tumours: Where are we now?","volume":"61","author":"Gleason","year":"2008","journal-title":"J. Clin. Pathol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/PAS.0b013e318200cfd5","article-title":"Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK","volume":"35","author":"Wang","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_15","unstructured":"Fletcher, C.D.M. (2021). Tumors of Soft tissue. Diagnostic Histopathology of Tumors, Elsevier. [5th ed.]."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.32604\/or.2024.050350","article-title":"Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment","volume":"32","author":"Chmiel","year":"2024","journal-title":"Oncol. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/01.pas.0000213393.57322.c7","article-title":"Inflammatory myofibroblastic tumor: Comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases","volume":"31","author":"Coffin","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/00000478-199508000-00001","article-title":"Extrapulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). A clinicopathologic and immunohistochemical study of 84 cases","volume":"19","author":"Coffin","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1053\/jpsu.2001.23970","article-title":"Inflammatory myofibroblastic tumor in children: Diagnosis and treatment","volume":"36","author":"Karnak","year":"2001","journal-title":"J. Pediatr. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/00000478-200412000-00009","article-title":"ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder","volume":"28","author":"Tsuzuki","year":"2004","journal-title":"Am. J Surg. Pathol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/hupa.2002.32213","article-title":"Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: How closely are they related to inflammatory fibroid polyps?","volume":"33","author":"Makhlouf","year":"2002","journal-title":"Hum. Pathol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S1010-7940(03)00678-X","article-title":"Inflammatory myofibroblastic tumor of the lung","volume":"25","author":"Sakurai","year":"2004","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1046\/j.1440-1673.2000.00820.x","article-title":"Pulmonary inflammatory pseudotumour in children","volume":"44","author":"Patankar","year":"2000","journal-title":"Australas Radiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.rcl.2015.12.005","article-title":"Inflammatory Myofibroblastic Tumors: Current Update","volume":"54","author":"Surabhi","year":"2016","journal-title":"Radiol. Clin. N. Am."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000358732","article-title":"Inflammatory myofibroblastic tumours of the urinary bladder: Multi-centre 18-year experience","volume":"94","author":"Teoh","year":"2015","journal-title":"Urol. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.urology.2014.05.039","article-title":"Inflammatory myofibroblastic tumors of the urinary bladder: A systematic review","volume":"84","author":"Teoh","year":"2014","journal-title":"Urology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1097\/01.pas.0000213280.35413.1b","article-title":"Inflammatory myofibroblastic tumors of the urinary tract: A clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma","volume":"30","author":"Montgomery","year":"2006","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.urology.2020.07.050","article-title":"Inflammatory Myofibroblastic Tumor of the Urinary Bladder and Ureter in Children: Experience of a Tertiary Referral Center","volume":"145","author":"Li","year":"2020","journal-title":"Urology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jpurol.2015.03.009","article-title":"Inflammatory myofibroblastic tumour of the bladder in children: A review","volume":"11","author":"Collin","year":"2015","journal-title":"J. Pediatr. Urol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/PAP.0000000000000164","article-title":"Myxoid Mesenchymal Tumors of the Uterus: An Update on Classification, Definitions, and Differential Diagnosis","volume":"24","author":"Busca","year":"2017","journal-title":"Adv. Anat. Pathol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000000330","article-title":"Inflammatory myofibroblastic tumor of the uterus: Clinical and pathologic review of 10 cases including a subset with aggressive clinical course","volume":"39","author":"Quick","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0000000000001525","article-title":"Inflammatory Myofibroblastic Tumor of the Uterus: An Immunohistochemical Study of 23 Cases","volume":"44","author":"Bennett","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/PAS.0000000000000909","article-title":"Inflammatory Myofibroblastic Tumors of the Female Genital Tract Are Under-recognized: A Low Threshold for ALK Immunohistochemistry Is Required","volume":"41","author":"Pickett","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/PGP.0000000000000175","article-title":"Inflammatory Myofibroblastic Tumor of the Placenta: A Report of a Novel Lesion in 2 Patients","volume":"34","author":"Banet","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/PAS.0000000000001044","article-title":"Inflammatory Myofibroblastic Tumor Associated with the Placenta: Short Tandem Repeat Genotyping Confirms Uterine Site of Origin","volume":"42","author":"Ladwig","year":"2018","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.humpath.2019.12.006","article-title":"Uterine inflammatory myofibroblastic tumors in pregnant women with and without involvement of the placenta: A study of 6 cases with identification of a novel TIMP3-RET fusion","volume":"97","author":"Cheek","year":"2020","journal-title":"Hum. Pathol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1097\/PAS.0000000000001481","article-title":"Pregnancy-associated Inflammatory Myofibroblastic Tumors of the Uterus Are Clinically Distinct and Highly Enriched for TIMP3-ALK and THBS1-ALK Fusions","volume":"44","author":"Devereaux","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1097\/01.pas.0000172189.02424.91","article-title":"Inflammatory myofibroblastic tumor of the uterus: A clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors","volume":"29","author":"Rabban","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/PAS.0000000000000801","article-title":"Uterine Inflammatory Myofibroblastic Tumors Frequently Harbor ALK Fusions with IGFBP5 and THBS1","volume":"41","author":"Haimes","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1309\/AJCPCG8D6JAQBVLG","article-title":"Polypoid laryngeal inflammatory myofibroblastic tumors: Misleading lesions: Description of six cases showing ALK overexpression","volume":"144","author":"Pierry","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00405-014-3026-2","article-title":"Inflammatory myofibroblastic tumors of the nasal cavity and paranasal sinus: A clinicopathologic study of 25 cases and review of the literature","volume":"272","author":"He","year":"2015","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12105-016-0744-3","article-title":"Sinonasal Inflammatory Myofibroblastic Tumor with Anaplastic Lymphoma Kinase 1 Rearrangement: Case Study and Literature Review","volume":"11","author":"Lahlou","year":"2017","journal-title":"Head Neck Pathol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Zhu, Z., Zha, Y., Wang, W., Wang, X., Gao, Y., and Lv, W. (2018). Inflammatory Myofibroblastic Tumors in Paranasal Sinus and Nasopharynx: A Clinical Retrospective Study of 13 Cases. Biomed. Res. Int., 2018.","DOI":"10.1155\/2018\/7928241"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/s41379-019-0406-6","article-title":"Infantile inflammatory myofibroblastic tumors: Clinicopathological and molecular characterization of 12 cases","volume":"33","author":"John","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s12032-010-9729-3","article-title":"Inflammatory myofibroblastic tumor of the head and neck","volume":"28","author":"Chen","year":"2011","journal-title":"Med. Oncol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.oraloncology.2011.09.004","article-title":"Head and neck inflammatory myofibroblastic tumor (IMT): Evaluation of clinicopathologic and prognostic features","volume":"48","author":"Ong","year":"2012","journal-title":"Oral Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.anndiagpath.2007.04.004","article-title":"Inflammatory myofibroblastic tumor of larynx: A benign lesion with variable morphological spectrum","volume":"11","author":"Idrees","year":"2007","journal-title":"Ann. Diagn. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/1097-0142(19951201)76:11<2217::AID-CNCR2820761107>3.0.CO;2-N","article-title":"Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm","volume":"76","author":"Wenig","year":"1995","journal-title":"Cancer"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1093\/ajcp\/94.5.538","article-title":"Inflammatory myofibroblastic tumor (plasma cell granuloma). Clinicopathologic study of 20 cases with immunohistochemical and ultrastructural observations","volume":"94","author":"Pettinato","year":"1990","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4132\/jptm.2017.01.12","article-title":"Clinicopathological Study of 18 Cases of Inflammatory Myofibroblastic Tumors with Reference to ALK-1 Expression: 5-Year Experience in a Tertiary Care Center","volume":"51","author":"Telugu","year":"2017","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/pbc.20294","article-title":"Pediatric inflammatory myofibroblastic tumor: Anaplastic lymphoma kinase (ALK) expression and prognosis","volume":"45","author":"Chun","year":"2005","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1148\/rg.2016150191","article-title":"Pediatric Fibroblastic and Myofibroblastic Tumors: A Pictorial Review","volume":"36","author":"Sargar","year":"2016","journal-title":"Radiographics"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1148\/rg.2018180192","article-title":"Primary Lung Tumors in Children: Radiologic-Pathologic Correlation from the Radiologic Pathology Archives","volume":"38","author":"Lichtenberger","year":"2018","journal-title":"Radiographics"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1177\/0284185113500165","article-title":"Computed tomography and magnetic resonance imaging findings of inflammatory myofibroblastic tumors of the head and neck","volume":"55","author":"Gao","year":"2014","journal-title":"Acta Radiol."},{"key":"ref_55","unstructured":"Folpe, A.L., and Nielsen, G.P. (2023). Bone and Soft Tissue Pathology, Elsevier. [2nd ed.]."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/01.MP.0000026615.04130.1F","article-title":"Expression of ALK1 and p80 in inflammatory myofibroblastic tumor and its mesenchymal mimics: A study of 135 cases","volume":"15","author":"Cessna","year":"2002","journal-title":"Mod. Pathol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1158\/1078-0432.CCR-11-0063","article-title":"Pulmonary inflammatory myofibroblastic tumor expressing a novel fusion, PPFIBP1-ALK: Reappraisal of anti-ALK immunohistochemistry as a tool for novel ALK fusion identification","volume":"17","author":"Takeuchi","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/his.12910","article-title":"ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours","volume":"69","author":"Yamamoto","year":"2016","journal-title":"Histopathology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/modpathol.2014.165","article-title":"Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors","volume":"28","author":"Hornick","year":"2015","journal-title":"Mod. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/his.14206","article-title":"TERT promoter mutation analysis as a surrogate to morphology and immunohistochemistry in problematic spindle cell lesions of the urinary bladder","volume":"77","author":"Bertz","year":"2020","journal-title":"Histopathology"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0002-9440(10)61711-7","article-title":"Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor","volume":"159","author":"Bridge","year":"2001","journal-title":"Am. J. Pathol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.humpath.2008.04.016","article-title":"An inflammatory myofibroblastic tumor in liver with ALK and RANBP2 gene rearrangement: Combination of distinct morphologic, immunohistochemical, and genetic features","volume":"39","author":"Chen","year":"2008","journal-title":"Hum. Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1097\/01.LAB.0000088856.49388.EA","article-title":"Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor","volume":"83","author":"Debelenko","year":"2003","journal-title":"Lab. Investig."},{"key":"ref_64","first-page":"2776","article-title":"Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors","volume":"59","author":"Griffin","year":"1999","journal-title":"Cancer Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)64550-6","article-title":"TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors","volume":"157","author":"Lawrence","year":"2000","journal-title":"Am. J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1440-1827.2006.02012.x","article-title":"Absence of human herpesvirus-8 and Epstein-Barr virus in inflammatory myofibroblastic tumor with anaplastic large cell lymphoma kinase fusion gene","volume":"56","author":"Yamamoto","year":"2006","journal-title":"Pathol. Int."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.humpath.2017.04.022","article-title":"A novel fusion of HNRNPA1-ALK in inflammatory myofibroblastic tumor of urinary bladder","volume":"69","author":"Inamura","year":"2017","journal-title":"Hum. Pathol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1158\/2159-8290.CD-14-0377","article-title":"Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions","volume":"4","author":"Lovly","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/path.4836","article-title":"ALK oncoproteins in atypical inflammatory myofibroblastic tumours: Novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma","volume":"241","author":"Lee","year":"2017","journal-title":"J. Pathol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/modpathol.3880352","article-title":"ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor","volume":"14","author":"Coffin","year":"2001","journal-title":"Mod. Pathol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/00000478-200111000-00003","article-title":"Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumor: A comparative immunohistochemical study","volume":"25","author":"Cook","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/PAS.0000000000000677","article-title":"ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors","volume":"40","author":"Alassiri","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/PAS.0000000000000404","article-title":"Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement","volume":"39","author":"Antonescu","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00000478-200106000-00007","article-title":"Anaplastic lymphoma kinase expression in inflammatory pseudotumors","volume":"25","author":"Chan","year":"2001","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jtho.2018.12.003","article-title":"Expanding the Molecular Characterization of Thoracic Inflammatory Myofibroblastic Tumors beyond ALK Gene Rearrangements","volume":"14","author":"Chang","year":"2019","journal-title":"J. Thorac. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1177\/0300060518780873","article-title":"Anaplastic lymphoma kinase-negative uterine inflammatory myofibroblastic tumor containing the ETV6-NTRK3 fusion gene: A case report","volume":"46","author":"Takahashi","year":"2018","journal-title":"J. Int. Med. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41379-020-00670-0","article-title":"Pseudosarcomatous myofibroblastic proliferations of the urinary bladder are neoplasms characterized by recurrent FN1-ALK fusions","volume":"34","author":"Acosta","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/pin.12796","article-title":"Vocal cord inflammatory myofibroblastic tumor with mucoid deposits harboring TIMP3-ALK fusion: A potential diagnostic pitfall","volume":"69","author":"Yorita","year":"2019","journal-title":"Pathol. Int."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/PAS.0000000000001735","article-title":"Clinicopathologic and Genomic Characterization of Inflammatory Myofibroblastic Tumors of the Head and Neck: Highlighting a Novel Fusion and Potential Diagnostic Pitfall","volume":"45","author":"Kerr","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/PAP.0000000000000440","article-title":"The \u201cOther\u201d Uterine Mesenchymal Neoplasms: Recent Developments and Emerging Entities","volume":"31","author":"Bennett","year":"2024","journal-title":"Adv. Anat. Pathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/modpathol.2017.69","article-title":"Inflammatory myofibroblastic tumor of the uterus: A clinicopathological, immunohistochemical, and molecular analysis of 13 cases highlighting their broad morphologic spectrum","volume":"30","author":"Bennett","year":"2017","journal-title":"Mod. Pathol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/PAS.0000000000001987","article-title":"Uterine Inflammatory Myofibroblastic Tumors: Proposed Risk Stratification Model Using Integrated Clinicopathologic and Molecular Analysis","volume":"47","author":"Ladwig","year":"2023","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejogrb.2015.07.003","article-title":"Inflammatory myofibroblastic tumour: Unexpected finding on placental examination","volume":"194","author":"Saeed","year":"2015","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/PGP.0000000000000323","article-title":"ALK-rearranged Inflammatory Myofibroblastic Tumor of the Placenta, With Observations on Site of Origin","volume":"36","author":"Schoolmeester","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.pathol.2018.05.008","article-title":"ALK-rearranged inflammatory myofibroblastic tumour of placental membranes","volume":"50","author":"Squires","year":"2018","journal-title":"Pathology"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.03.014","article-title":"Uterine inflammatory myofibroblastic tumor involving the decidua of the extraplacental membranes: Report of a case with a TIMP3-ROS1 gene fusion","volume":"100","author":"Schoolmeester","year":"2020","journal-title":"Hum. Pathol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.humpath.2020.09.005","article-title":"Inflammatory myofibroblastic tumors associated with the placenta: A series of 9 cases","volume":"106","author":"Makhdoum","year":"2020","journal-title":"Hum. Pathol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/PGP.0000000000000893","article-title":"Inflammatory Myofibroblastic Tumor of the Placenta with Subsequent Successful Pregnancy and Benign Hysterectomy: A Case Report With 59-Month Follow-up","volume":"42","author":"Schwartz","year":"2023","journal-title":"Int. J. Gynecol. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"154500","DOI":"10.1016\/j.prp.2023.154500","article-title":"Uterine inflammatory myofibroblastic tumor with THBS1-INSR fusion","volume":"246","author":"Sim","year":"2023","journal-title":"Pathol. Res. Pract."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"231","DOI":"10.4132\/jptm.2022.05.08","article-title":"Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: A rare entity and a literature review","volume":"56","author":"Singh","year":"2022","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Li, X., Zheng, J., Li, X., Chen, Y., Liu, K., Li, F., and Lu, Z. (2023). Case Report: Ensartinib for gastric epithelioid inflammatory myofibrosarcoma with STRN-ALK fusion. Front. Oncol., 13.","DOI":"10.3389\/fonc.2023.1252221"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"141","DOI":"10.4132\/jptm.2024.04.12","article-title":"Primary epithelioid inflammatory myofibroblastic sarcoma of the brain with EML4::ALK fusion mimicking intra-axial glioma: A case report and brief literature review","volume":"58","author":"Kim","year":"2024","journal-title":"J. Pathol. Transl. Med."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1097\/PAS.0000000000002231","article-title":"Myxoid Inflammatory Myofibroblastic Sarcoma: Clinicopathologic Analysis of 25 Cases of a Distinctive Sarcoma with Deceptively Bland Morphology and Aggressive Clinical Behavior","volume":"48","author":"Papke","year":"2024","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","article-title":"Consensus statement on the pathology of IgG4-related disease","volume":"25","author":"Deshpande","year":"2012","journal-title":"Mod. Pathol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/his.13526","article-title":"Pseudosarcomatous myofibroblastic proliferations of the genitourinary tract are genetically different from nodular fasciitis and lack USP6, ROS1 and ETV6 gene rearrangements","volume":"73","author":"Jebastin","year":"2018","journal-title":"Histopathology"},{"key":"ref_96","unstructured":"The WHO Classification of Tumours Editorial Board (2019). Inflammatory fibroid polyp. WHO Classification of Tumours. Digestive system Tumours, IARC Press. [5th ed.]."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/pin.12625","article-title":"Colonic inflammatory fibroid polyp with PDGFRA expression","volume":"68","author":"Sugawara","year":"2018","journal-title":"Pathol. Int."},{"key":"ref_98","unstructured":"The WHO Editorial Board (2020). Nodular fasciitis. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_99","unstructured":"The WHO Editorial Board (2020). Desmoid fibromatosis. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_100","unstructured":"The WHO Editorial Board (2020). Atypical lipomatous tumour\/well-differentiated liposarcoma. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/00000478-199705000-00003","article-title":"Well-differentiated inflammatory liposarcoma: An uncommon and easily overlooked variant of a common sarcoma","volume":"21","author":"Kraus","year":"1997","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_102","unstructured":"The WHO Editorial Board (2020). Low-grade myofibroblastic sarcoma. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/00000478-199810000-00008","article-title":"Low-grade myofibroblastic sarcoma: Analysis of 18 cases in the spectrum of myofibroblastic tumors","volume":"22","author":"Mentzel","year":"1998","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_104","unstructured":"The WHO Editorial Board (2020). Myxoinflammatory fibroblastic sarcoma. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/gcc.20897","article-title":"Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor","volume":"50","author":"Antonescu","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.humpath.2016.02.005","article-title":"TGFBR3 and MGEA5 rearrangements are much more common in \u201chybrid\u201d hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: A morphological and fluorescence in situ hybridization study","volume":"53","author":"Zreik","year":"2016","journal-title":"Hum. Pathol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1002\/path.2513","article-title":"Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions","volume":"217","author":"Hallor","year":"2009","journal-title":"J. Pathol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1097\/PAS.0000000000000899","article-title":"Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors","volume":"41","author":"Kao","year":"2017","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_109","unstructured":"The WHO Editorial Board (2020). Inflammatory leiomyosarcoma. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41379-020-00703-8","article-title":"\u201cInflammatory Leiomyosarcoma\u201d and \u201cHistiocyte-rich Rhabdomyoblastic Tumor\u201d: A clinicopathological, immunohistochemical and genetic study of 13 cases, with a proposal for reclassification as \u201cInflammatory Rhabdomyoblastic Tumor\u201d","volume":"34","author":"Cloutier","year":"2021","journal-title":"Mod. Pathol."},{"key":"ref_111","unstructured":"The WHO Editorial Board (2020). Embryonal rhabdomyosarcoma. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1200\/JCO.2014.55.6787","article-title":"Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children\u2019s Oncology Group","volume":"32","author":"Walterhouse","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1200\/JCO.2018.77.9694","article-title":"Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report from the Children\u2019s Oncology Group","volume":"36","author":"Hawkins","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_114","unstructured":"The WHO Editorial Board (2020). Gastrointestinal stromal tumour. WHO Classification of Tumours. Soft Tissue and Bone Tumours, IARC Press. [5th ed.]."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pas.0000146010.92933.de","article-title":"Gastrointestinal stromal tumors of the stomach: A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am. J Surg. Pathol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1097\/01.pas.0000172190.79552.8b","article-title":"Gastrointestinal stromal tumors of the stomach in children and young adults: A clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases with long-term follow-up and review of the literature","volume":"29","author":"Miettinen","year":"2005","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1073\/pnas.1009199108","article-title":"Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations","volume":"108","author":"Janeway","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/modpathol.2012.153","article-title":"Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors","volume":"26","author":"Wagner","year":"2013","journal-title":"Mod. Pathol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/PAS.0b013e3181d6150d","article-title":"Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types","volume":"34","author":"Gill","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1097\/PAS.0b013e3182260752","article-title":"Succinate dehydrogenase-deficient GISTs: A clinicopathologic, immunohistochemical, and molecular genetic study of 66 gastric GISTs with predilection to young age","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/modpathol.2010.185","article-title":"SDHB immunohistochemistry: A useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors","volume":"24","author":"Gaal","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_122","unstructured":"The WHO Classification of Tumours Editorial Board (2024). EBV-positive inflammatory follicular dendritic cell sarcoma. WHO Classification of Tumours. Haematolymphoid Tumors, IARC Press. [5th ed.]."},{"key":"ref_123","unstructured":"The WHO Classification of Tumours Editorial Board (2024). Follicular dendritic cell sarcoma. WHO Classification of Tumours. Haematolymphoid Tumors, IARC Press. [5th ed.]."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/his.15194","article-title":"Advances in uterine inflammatory myofibroblastic tumours: Diagnostic challenges and risk stratification","volume":"85","author":"Umetsu","year":"2024","journal-title":"Histopathology"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"100852","DOI":"10.1016\/j.gore.2021.100852","article-title":"Uterine mesenchymal tumors harboring ALK fusions and response to ALK-targeted therapy","volume":"37","author":"Kyi","year":"2021","journal-title":"Gynecol. Oncol. Rep."},{"key":"ref_126","unstructured":"National Comprehensive Cancer Network (2024). Clinical Practice Guidelines for Uterine Neoplasms (Version 2.2024), NCCN. Available online: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/sarcoma.pdf."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa1311107","article-title":"Ceritinib in ALK-rearranged non-small-cell lung cancer","volume":"370","author":"Shaw","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ejca.2021.07.016","article-title":"Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE","volume":"156","author":"Kubickova","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-2600(18)30116-4","article-title":"Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): A multicentre, single-drug, prospective, non-randomised phase 2 trial","volume":"6","author":"Sufliarsky","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S2213-2600(18)30147-4","article-title":"Targeting ALK in inflammatory myofibroblastic tumours","volume":"6","author":"Villalobos","year":"2018","journal-title":"Lancet Respir. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1158\/1541-7786.MCR-18-0171","article-title":"ALK Fusion Partners Impact Response to ALK Inhibition: Differential Effects on Sensitivity, Cellular Phenotypes, and Biochemical Properties","volume":"16","author":"Childress","year":"2018","journal-title":"Mol. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"e283","DOI":"10.1097\/MPH.0000000000000604","article-title":"Neoadjuvant Treatment with Cyclooxygenase-2 Inhibitor and Prednisolone Allows Conservative Surgery for Inflammatory Myofibroblastic Tumor of the Bladder","volume":"38","author":"Tsuma","year":"2016","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ejca.2019.12.021","article-title":"Inflammatory myofibroblastic tumor: The experience of the European pediatric Soft Tissue Sarcoma Study Group (EpSSG)","volume":"127","author":"Casanova","year":"2020","journal-title":"Eur. J. Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"e1777","DOI":"10.1634\/theoncologist.2020-0352","article-title":"The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis","volume":"25","author":"Baldi","year":"2020","journal-title":"Oncologist"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cncr.24684","article-title":"Inflammatory myofibroblastic tumors in childhood: A report from the Italian Cooperative Group studies","volume":"116","author":"Alaggio","year":"2010","journal-title":"Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/PAP.0000000000000479","article-title":"Risk Stratification of Miscellaneous Uterine Mesenchymal Neoplasms: The Role of Morphology, Immunohistochemistry, and Molecular Testing","volume":"32","author":"Ladwig","year":"2025","journal-title":"Adv. Anat. Pathol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.advms.2022.02.002","article-title":"What do we know about inflammatory myofibroblastic tumors?\u2014A systematic review","volume":"67","author":"Siemion","year":"2022","journal-title":"Adv. Med. Sci."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Gros, L., Dei Tos, A.P., Jones, R.L., and Digklia, A. (2022). Inflammatory Myofibroblastic Tumour: State of the Art. Cancers, 14.","DOI":"10.3390\/cancers14153662"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"e29131","DOI":"10.1002\/pbc.29131","article-title":"Single-agent rituximab for treatment of multifocal and multiple relapsed pulmonary inflammatory myofibroblastic tumor in an adolescent patient","volume":"68","author":"Farris","year":"2021","journal-title":"Pediatr. Blood Cancer"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/8\/1327\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:14:49Z","timestamp":1760030089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/8\/1327"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":139,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cancers17081327"],"URL":"https:\/\/doi.org\/10.3390\/cancers17081327","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]}}}